GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dai Han Pharmaceutical Co Ltd (XKRX:023910) » Definitions » Capital Expenditure

Dai Han Pharmaceutical Co (XKRX:023910) Capital Expenditure : ₩-24,469.72 Mil (TTM As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Dai Han Pharmaceutical Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Dai Han Pharmaceutical Co's cash flow for capital expenditures for the three months ended in Mar. 2024 was ₩-4,567 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-24,469.72 Mil.

Dai Han Pharmaceutical Co Capital Expenditure Historical Data

The historical data trend for Dai Han Pharmaceutical Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dai Han Pharmaceutical Co Capital Expenditure Chart

Dai Han Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17,304.86 -5,360.24 -11,850.08 -8,621.23 -21,280.37

Dai Han Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,377.95 -4,883.73 -5,588.65 -9,430.05 -4,567.29

Dai Han Pharmaceutical Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-24,469.72 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dai Han Pharmaceutical Co (XKRX:023910) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dai Han Pharmaceutical Co Ltd (XKRX:023910) » Definitions » Capital Expenditure
Comparable Companies
XKRX:082800 XKRX:214390 XKRX:002390 XKRX:176750 XKRX:002620 XKRX:293780 XKRX:067080 XKRX:001360 XKRX:061250 XKRX:011040 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
8-3, 4-Ga Yangpyeong-dong, Yeongdeungpo-gu, Seoul, KOR
Website
http://www.daihan.com
Dai Han Pharmaceutical Co Ltd is a South Korea based company engages in the manufacture, supply, and distribution of pharmaceutical products such as infusions, injections, drugs used in contrast media, drugs used for external uses and quasi-drugs.

Dai Han Pharmaceutical Co (XKRX:023910) Headlines

No Headlines